The study was aimed at assessing the ability of CpG ODN class C in combination with irradiated tumor cells to trigger the antitumor immunity in experimental tumor model (intraperitoneal B16F1 on C57Bl/6 mice). Results of the study clearly showed that vaccine (CpG ODN class C and irradiated tumor cells) powerfully triggers the immune system to prevent tumor development. By this vaccine, the APCs are manipulated to differentiate and to activate the primary and the secondary immune response. When an adequate number of APCs is affected then the long-lasting immunity is achieved.
B.04 Guest lecture
COBISS.SI-ID: 707451I participated in organization of the scientific/professional conference from the area of oncology expertise. The objectives were to introduce financing procedures for newly registered oncology drugs and methods, to identify the problems associated with this, and to propose certain solutions.
B.01 Organiser of a scientific meeting
COBISS.SI-ID: 238942208